	US 12,290,442 B2
	Medical product and medical kit for use when treating a bone cavity, in particular for use when filling and/or closing a bone cavity
Ursula Mattes, Renquishausen (DE); and Michael Utz, Tuttlingen (DE)
Assigned to AESCULAP AG, Tuttlingen (DE)
Filed by Aesculap AG, Tuttlingen (DE)
Filed on Apr. 29, 2021, as Appl. No. 17/244,850.
Application 17/244,850 is a continuation of application No. 16/063,617, abandoned, previously published as PCT/EP2016/081591, filed on Dec. 16, 2016.
Claims priority of application No. 10 2015 226063.1 (DE), filed on Dec. 18, 2015.
Prior Publication US 2021/0244541 A1, Aug. 12, 2021
Int. Cl. A61F 2/28 (2006.01); A61F 2/44 (2006.01); A61L 27/04 (2006.01); A61L 27/06 (2006.01); A61L 27/10 (2006.01); A61L 27/14 (2006.01); A61L 27/16 (2006.01); A61L 27/18 (2006.01); A61L 27/20 (2006.01); A61L 27/50 (2006.01); A61L 27/54 (2006.01); A61F 2/30 (2006.01)

CPC A61F 2/28 (2013.01) [A61F 2/44 (2013.01); A61L 27/04 (2013.01); A61L 27/045 (2013.01); A61L 27/06 (2013.01); A61L 27/10 (2013.01); A61L 27/14 (2013.01); A61L 27/16 (2013.01); A61L 27/18 (2013.01); A61L 27/20 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61F 2002/2835 (2013.01); A61F 2002/2839 (2013.01); A61F 2002/30062 (2013.01); A61F 2002/30113 (2013.01); A61F 2002/30115 (2013.01); A61F 2002/30138 (2013.01); A61F 2002/30171 (2013.01); A61F 2002/302 (2013.01); A61F 2002/30588 (2013.01); A61F 2002/30909 (2013.01); A61F 2002/3092 (2013.01); A61F 2002/4415 (2013.01); A61F 2002/4495 (2013.01); A61L 2300/258 (2013.01); A61L 2300/404 (2013.01); A61L 2300/406 (2013.01); A61L 2300/41 (2013.01); A61L 2300/414 (2013.01); A61L 2300/42 (2013.01); A61L 2430/02 (2013.01)]

23 Claims

1. A medical product for use in treating a bone cavity, wherein the product comprises a plurality of interconnected members, wherein each member has a peripheral boundary and the boundaries of adjacent members interlock, wherein the product comprises a three-dimensional structure composed of the members, wherein the three-dimensional structure further comprises a multilayer construction, wherein each layer has interconnected members, wherein the respective boundaries of members engage with adjacent layers, wherein the boundaries of adjacent members interlock in such a way that each of them engages with a through opening, a through hole, or a through channel of at least one adjacent member, wherein the medical product has additional structural elements in addition to the members, wherein the additional structural elements are located in hollow spaces and/or interstices of the medical product, and wherein the additional structural elements are configured to be larger than the members and wherein the additional structural elements are not connected to the members.